Paper8098047
Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.
Hait WN and 3 others. J Clin Invest, 1993. Cited by 35 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents. Papers, record 8098047. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8098047
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Cyclosporine | Major topic |
| Drug Resistance | Major topic |
| Flupenthixol | Major topic |
| Membrane Glycoproteins | Major topic |
| Vinblastine | Major topic |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Blotting, Southern | |
| Cell Differentiation | |
| Cytarabine | |
| DNA | |
| Gene Expression | |
| Hemin | |
| Humans | |
| Kinetics | |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | |
| RNA, Messenger | |
| Transfection | |
| Tumor Cells, Cultured |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 08341 | NCI NIH HHS | United States | P01CA008341 | PubMed and NIH | NIH RePORTER |
| CA 43888 | NCI NIH HHS | United States | R01CA043888 | PubMed and NIH | NIH RePORTER |
| P02CA008341 | NIH | NIH RePORTER |
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4005839 | Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. | Cancer Res | 1985 | https://conductscience.org/library/papers/4005839 | PubMed |
| 2 | 2892823 | Detection of multidrug resistance markers, P-glycoprotein and mdr1 mRNA, in human leukemia cells. | Jpn J Cancer Res | 1987 | https://conductscience.org/library/papers/2892823 | PubMed |
| 3 | 2898143 | A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/2898143 | PubMed |
| 4 | 3165724 | Correction of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3165724 | PubMed |
| 5 | 3045133 | Altered molecular properties of tubulin in a multidrug-resistant variant of Chinese hamster cells selected for resistance to vinca alkaloids. | J Cell Physiol | 1988 | https://conductscience.org/library/papers/3045133 | PubMed |
| 6 | 2562856 | Expression of a multidrug resistance gene in human cancers. | J Natl Cancer Inst | 1989 | https://conductscience.org/library/papers/2562856 | PubMed |
| 7 | 2535960 | Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells. | Cancer Res | 1989 | https://conductscience.org/library/papers/2535960 | PubMed |
| 8 | 2910487 | Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein B23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells. | Cancer Res | 1989 | https://conductscience.org/library/papers/2910487 | PubMed |
| 9 | 2563302 | Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance. | Mol Pharmacol | 1989 | https://conductscience.org/library/papers/2563302 | PubMed |
| 10 | 2804973 | Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues. | Cancer Res | 1989 | https://conductscience.org/library/papers/2804973 | PubMed |
| 11 | 2572588 | Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents. | J Biol Chem | 1989 | https://conductscience.org/library/papers/2572588 | PubMed |
| 12 | 1967174 | Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. | J Biol Chem | 1990 | https://conductscience.org/library/papers/1967174 | PubMed |
| 13 | 1968358 | Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines. | Cancer Res | 1990 | https://conductscience.org/library/papers/1968358 | PubMed |
| 14 | 2576973 | Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavage. | Cancer Commun | 1989 | https://conductscience.org/library/papers/2576973 | PubMed |
| 15 | 2640154 | Activity of cyclosporin A and a non-immunosuppressive cyclosporin against multidrug resistant leukemic cell lines. | Cancer Commun | 1989 | https://conductscience.org/library/papers/2640154 | PubMed |
| 16 | 2217530 | Pharmacology of drugs that alter multidrug resistance in cancer. | Pharmacol Rev | 1990 | https://conductscience.org/library/papers/2217530 | PubMed |
| 17 | 1703776 | Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells. | Cell Growth Differ | 1990 | https://conductscience.org/library/papers/1703776 | PubMed |
| 18 | 1676843 | Multidrug-resistant human neuroblastoma cells are more differentiated than controls and retinoic acid further induces lineage-specific differentiation. | Prog Clin Biol Res | 1991 | https://conductscience.org/library/papers/1676843 | PubMed |
| 19 | 1349840 | Why haven't we cured multidrug resistant tumors? | Oncol Res | 1992 | https://conductscience.org/library/papers/1349840 | PubMed |
| 20 | 1360276 | Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. | Oncol Res | 1992 | https://conductscience.org/library/papers/1360276 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39314886 | Feeder cell training shapes the phenotype and function of in vitro expanded natural killer cells. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39314886 | PubMed |
| 30857233 | Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent Signaling. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/30857233 | PubMed |
| 29363591 | Topoisomerases as anticancer targets. | Biochem J | 2018 | https://conductscience.org/library/papers/29363591 | PubMed |
| 28450921 | Research on the effect of ginseng polysaccharide on apoptosis and cell cycle of human leukemia cell line K562 and its molecular mechanisms. | Exp Ther Med | 2017 | https://conductscience.org/library/papers/28450921 | PubMed |
| 25360237 | Practical management of patients with chronic myeloid leukemia who develop tyrosine kinase inhibitor-resistant BCR-ABL1 mutations. | Ther Adv Hematol | 2014 | https://conductscience.org/library/papers/25360237 | PubMed |
| 24070327 | Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines? | Biosci Rep | 2013 | https://conductscience.org/library/papers/24070327 | PubMed |
| 23263730 | Megakaryocytic differentiation in human chronic myelogenous leukemia K562 cells induced by ionizing radiation in combination with phorbol 12-myristate 13-acetate. | J Radiat Res | 2013 | https://conductscience.org/library/papers/23263730 | PubMed |
| 20938465 | Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype. | Pharmacogenomics J | 2012 | https://conductscience.org/library/papers/20938465 | PubMed |
| 19762091 | Is resistance useless? Multidrug resistance and collateral sensitivity. | Trends Pharmacol Sci | 2009 | https://conductscience.org/library/papers/19762091 | PubMed |
| 7765329 | Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro. | Cytotechnology | 1993 | https://conductscience.org/library/papers/7765329 | PubMed |
| 7765325 | Pharmacologic circumvention of multidrug resistance. | Cytotechnology | 1993 | https://conductscience.org/library/papers/7765325 | PubMed |
| 7636888 | Drug-transport and volume-activated chloride channel functions in human erythroleukemia cells: relation to expression level of P-glycoprotein. | J Membr Biol | 1995 | https://conductscience.org/library/papers/7636888 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8098047
GET https://conductscience.org/api/papers/v1/8098047/references?page=2